| 2024 |
Johan, M. Z., Pyne, N. T., Kolesnikoff, N., Poltavets, V., Esmaeili, Z., Woodcock, J. M., . . . Samuel, M. S. (2024). Accelerated Closure of Diabetic Wounds by Efficient Recruitment of Fibroblasts upon Inhibiting a 14-3-3/ROCK Regulatory Axis. The Journal of Investigative Dermatology, 144(11), 2562-2573.e4.
DOI Scopus1 WoS1 Europe PMC1 |
| 2022 |
Ebert, L. M., Vandyke, K., Johan, M. Z., DeNichilo, M., Tan, L. Y., Myo Min, K. K., . . . Bonder, C. S. (2022). Desmoglein-2 expression is an independent predictor of poor prognosis patients with multiple myeloma. Molecular Oncology, 16(6), 1221-1240.
DOI Scopus11 WoS12 Europe PMC11 |
| 2022 |
Tan, L. Y., Cockshell, M. P., Moore, E., Myo Min, K. K., Ortiz, M., Johan, M. Z., . . . Bonder, C. S. (2022). Vasculogenic mimicry structures in melanoma support the recruitment of monocytes. OncoImmunology, 11(1), e2043673-1-e2043673-18.
DOI Scopus18 WoS19 Europe PMC19 |
| 2020 |
Boyle, S. T., Johan, M. Z., & Samuel, M. S. (2020). Tumour-directed microenvironment remodelling at a glance. Journal of Cell Science, 133(24), jcs247783-1-jcs247783-9.
DOI Scopus14 WoS13 Europe PMC8 |
| 2019 |
Johan, M. Z., & Samuel, M. S. (2019). Rho–ROCK signaling regulates tumor-microenvironment interactions. Biochemical Society Transactions, 47(1), 101-108.
DOI Scopus50 WoS46 Europe PMC36 |
| 2019 |
Johan, M. Z., Ingman, W. V., Robertson, S. A., & Hull, M. L. (2019). Macrophages infiltrating endometriosis-like lesions exhibit progressive phenotype changes in a heterologous mouse model. Journal of Reproductive Immunology, 132, 1-8.
DOI Scopus32 WoS30 Europe PMC28 |
| 2018 |
Cazet, A., Hui, M., Elsworth, B., Wu, S., Roden, D., Chan, C., . . . Swarbrick, A. (2018). Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer. Nature Communications, 9(1), 2897N-1-2897N-18.
DOI Scopus354 WoS338 Europe PMC324 |
| 2016 |
Ebert, L. M., Tan, L. Y., Johan, M. Z., Min, K. K. M., Cockshell, M. P., Parham, K. A., . . . Bonder, C. S. (2016). A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis. Angiogenesis, 19(4), 463-486.
DOI Scopus38 WoS39 Europe PMC30 |
| 2016 |
Tan, L., Mintoff, C., Johan, M., Ebert, B., Fedele, C., Zhang, Y., . . . Ebert, L. (2016). Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome. Oncotarget, 7(29), 46492-46508.
DOI Scopus46 WoS46 Europe PMC42 |
| 2015 |
McGuane, J. T., Watson, K. M., Zhang, J., Johan, M. Z., Wang, Z., Kuo, G., . . . Hull, M. L. (2015). Seminal plasma promotes lesion development in a xenograft model of endometriosis. American Journal of Pathology, 185(5), 1409-1422.
DOI Scopus13 WoS10 Europe PMC9 |
| 2012 |
Hull, M., Johan, M., Hodge, W., Robertson, S., & Ingman, W. (2012). Host-derived TGFB1 deficiency suppresses lesion development in a mouse model of endometriosis. American Journal of Pathology, 180(3), 880-887.
DOI Scopus76 WoS66 Europe PMC58 |
